Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial proteoglycans inhibit bFGF binding and mitogenesis

K E Forsten1, N A Courant, M A Nugent

  • 1Department of Biochemistry, Boston University School of Medicine, Massachusetts 02118, USA.

Journal of Cellular Physiology
|August 1, 1997
PubMed
Summary

Endothelial cells produce heparan sulfate proteoglycans that inhibit basic fibroblast growth factor (bFGF) activity, preventing vascular smooth muscle cell proliferation and maintaining vascular homeostasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heparan sulfate-protein binding specificity.

Biochemistry. Biokhimiia·2013
Same author

Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.

Oncogene·2009
Same author

Heparinase treatment of bovine smooth muscle cells inhibits fibroblast growth factor-2 binding to fibroblast growth factor receptor but not FGF-2 mediated cellular proliferation.

Angiogenesis·2003
Same author

TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing.

Molecular pathology : MP·2002
Same author

Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment.

Journal of cellular physiology·2001
Same author

IGF-I stimulation of extracellular acidification is not linked to cell proliferation for autocrine cells.

Endocrine·2001

Area of Science:

  • Vascular Biology
  • Cell Signaling
  • Proteoglycan Biochemistry

Background:

  • Basic fibroblast growth factor (bFGF) is a mitogen for vascular smooth muscle cells, implicated in proliferative vascular disorders.
  • Heparan sulfate proteoglycans (HSPGs) modulate bFGF activity through interactions with heparin or heparan sulfate.
  • Endothelial conditioned medium previously shown to inhibit bFGF binding and proliferation.

Purpose of the Study:

  • Isolate and characterize endothelial cell-secreted proteoglycans responsible for bFGF inhibitory activity.
  • Determine the relationship between proteoglycan structure and bFGF inhibitory function.
  • Investigate the role of endothelial HSPGs in maintaining vascular homeostasis.

Main Methods:

  • Isolation and fractionation of proteoglycans from endothelial cell conditioned medium (PG-A and PG-B).

Related Experiment Videos

  • Assays for bFGF binding to vascular smooth muscle cells.
  • Measurement of bFGF-stimulated vascular smooth muscle cell proliferation.
  • Analysis of proteoglycan core proteins and heparan sulfate chain size.

    • Main Results:

    • Endothelial proteoglycans were isolated and confirmed to inhibit bFGF binding and proliferation.
    • A larger fraction (PG-A) exhibited greater inhibitory activity than a smaller fraction (PG-B).
    • PG-A possessed larger heparan sulfate chains and an additional core protein, binding more bFGF.

    Conclusions:

    • Endothelial heparan sulfate proteoglycans directly bind bFGF, preventing its interaction with vascular smooth muscle cells.
    • The size of heparan sulfate chains and core protein composition influence inhibitory potency.
    • Endothelial HSPGs play a crucial role in inhibiting bFGF-induced mitogenesis and maintaining vascular homeostasis.